2025 HCPCS Code J9250
Methotrexate sodium, 5 mg
TAGS: methotrexate| Notice | HCPCS J9250 terminated on March 31, 2024. |
| Short Description | Methotrexate sodium inj |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | D - Special coverage instructions apply |
| HCPCS Code Added Date | January 01, 1994 |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- J9185 - Fludarabine phosphate inj
- J9190 - Fluorouracil injection
- J9196 - Inj gemcitabine hcl (accord)
- J9198 - Inj. infugem, 100 mg
- J9199 - Injection, infugem, 200 mg
- J9200 - Floxuridine injection
- J9201 - In gemcitabine hcl nos 200mg
- J9202 - Goserelin acetate implant
- J9203 - Gemtuzumab ozogamicin 0.1 mg
- J9204 - Inj mogamulizumab-kpkc, 1 mg
- J9205 - Inj irinotecan liposome 1 mg
- J9206 - Irinotecan injection
- J9207 - Ixabepilone injection
- J9208 - Ifosfamide injection
- J9209 - Mesna injection
- J9210 - Inj., emapalumab-lzsg, 1 mg
- J9211 - Idarubicin hcl injection
- J9212 - Interferon alfacon-1 inj
- J9213 - Interferon alfa-2a inj
- J9214 - Interferon alfa-2b inj